arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

Pluri Inc.

PLUR
$1.11 ▲ +0.03 (+2.78%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
66 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
85
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Pluri Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth -15.8%
Op. Margin None
ROIC 24.1%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$335.00K
↓ -15.8%
Net Income Profit after all expenses
$-5.88M
↑ +22.6%
FCF / Share Free cash flow per share
$-0.45
↑ +39.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
98
Cash Quality
51

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 66 quarters